Study: Treatments for Hep C Improving
WASHINGTON, D.C. - A committee convened by the National Institutes of Health (NIH) has found that treatment for the hepatitis C virus (HCV) has significantly improved during the past five years.
Sustained response rates have reportedly increased from 15 percent to 50 percent from treatment with combination therapies. Specifically, interferon and the antiviral drug ribavirin have improved the treatment of patients dramatically.
HCV, which is the leading cause of liver disease and liver cancer, has infected an estimated 4 million Americans.
Information from www.azcentral.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
